Category

PlosOne

Esteban R, Domínguez-Hernández R, Martín-Escudero V, Casado MA

 

 

Clinical and economic value of sofosbuvir-based regimens in the treatment of chronic hepatitis C in Spain
Plos One. Doi.org/10.1371/journal.pone.0278544

García-Herola A, Domínguez-Hernández R, Casado MA

 

 

Clinical and economic impact of an alert system in primary care for the detection of patients with chronic hepatitis C
PLoS One. 2021; 16(12)

Blanco-Dominguez I, Duch F, Polo V, Abad JM, Gomez-Barrera M, Garcia-Martin E

 

 

Correlation and regression analysis between residual gradation and uncorrected visual acuity one year after refractive surgery with LASIK, FS-LASIK, PRK, PRK Xtra techniques and the implantation of ICL® posterior chamber phakic lens in myopic correction
PLoS One. 2020;15(9):e0238399. doi: 10.1371/journal.pone.0238399. eCollection 2020

Buti M, Manzano ML, Morillas RM, García-Retortillo M, Martin L, Prieto M, Gutiérrez ML, Suarez E, Gómez-Rubio M, López J, Castillo P, Rodríguez M, Zozaya JM, Simón MA, Morano LE, Calleja JL, Yébenes M, Esteban R

 

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti- HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Plos One 2017. Doi.org/10.1371/journal.pone.0184550

Romero-Gómez M, Turnes J, Ampuero J, Oyagüez I, Cuenca B, González-García J, Muñoz-Molina B, Aguilar R, Leal S, Planas R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Casado MA, Solà R

 

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: The Optim Study
PLoS One.2015;10(3):e0122613.doi:10.1371/journal.pone.0122613